We're on a mission to revolutionize women's health care.

Team

LiGalli Profile Marga

Marga
Mathijssen

CEO
LiGalli Profile Godert1

Godert
Vinkesteijn

CFO
LiGalli Profile Thijs

Thijs
van Oorschot

CTO
LiGalli Profile Bart

Bart
van Rossum

CMO
LiGalli Profile Tanja

Tanja
Breum

Business Development Manager
LiGalli Profile Barry

Barry
van Amsterdam

Business
Analyst
LiGalli Profile Oda

Oda
Heerema-Snoep

Product Usability Engineer
LiGalli Profile Andrea

Andrea
Brand

Operational Partners & Procurement Manager
LiGalli Profile Marie-Pauline

Marie-Pauline
Luger

Communication Specialist
LiGalli Profile Sophia

Sophia
Lam

QA/RA
Manager
1576832361710

Hyeonji
Choi

Quality
Officer

Advisors

LiGalli Profile Maaike (Placeholder)

Maaike
Addicks

Medical Advisor
LiGalli Profile Martin

Martin
Walraven

Pharma Development & Regulatory Advisor
LiGalli Profile Victor

Victor
Nickolson

Pre-Clinical & Pharma Advisor
miranda-de-jager

Miranda
de Jager

CMC Advisor
LiGalli Profile Maarten

Maarten
Wiegerinck

Medical Advisor
LiGalli Profile Eveline

Eveline
Moret

Clinical Trial
Assistant

Supervisory Board

RAET

Cees
van den Heijkant

Chairman
LiGalli Profile Willem

Willem
de Laat

Founder & Member
circle-cropped (9) (1)

Carl
Thys

Member

We leverage on the knowledge and experience of our partners

To fulfill our mission, we partner with the most creative minds and top experts in the field.

Our organization is built upon a team of experts with an extensive network of specialized companies we work with for product development and research.

Edit Template

LiGalli aspires to significantly enhance the quality of life and care of women by empowering patients and health care professionals with intelligent drug delivery and diagnostics.

Personalized drug administration and diagnoses are seen as the best way to treat patients. 

Why we care

Women’s diseases need new attention
  • Women’s health has been underrepresented in medical investment, research, and innovation.
  • Medical solutions for women have not yet been fully explored because of still current male-first approach.
Existing solutions are not sufficient ​
  • Millions of women experience problems, side effects, and intolerability related to current treatments.
  • Women are 50-75% more likely to have adverse reaction to medications than men.  
  • Certain side effects that are typically experienced with oral drug intake may be reduced through the vaginal route.
Femtech is on the rise
  • The lack of innovation in women’s health has led to current solutions that do not adequately support women.
  • This gap leads to poorer quality of life and lower health outcomes for women.

Get in touch

Office
Leiden Bio Science Park – BioPartner 1

Address
J.H. Oortweg 21
2333 CH Leiden
The Netherlands

Menu

Home
Product
Science
Company
News
Contact
Edit Template
Disclaimer policy
Privacy & Cookies
Edit Template